Accelovance named “Best CRO”
Wednesday, April 20, 2011
Accelovance, a privately held CRO, has been named the “Best Contract Research Organization (CRO)” for a third consecutive year. The World Vaccine Congress hosted its annual Vaccine Industry Excellence (ViE) Awards to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry over the past 12 months.
“Quality and commitment are what define our organization,” remarked Lee Barsky, vice president of CRO services at Accelovance. “It is equally rewarding to see how our diverse service offering helps sponsors maintain growth despite challenging times in the industry.”